Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

• Status: Recruiting
• Trial end date: 2020-09-30
• Target enrollment: 0
• Participant gender: Female

Summary

In the present study will be compared Carbetocin with ergometrin in the prevention of postpartum haemorrhage (PPH) in parturients that are undergoing caesarean section and are not presenting risk factors for PPH. As indicators will be used intraoperative blood loss, as well as the value of hemoglobin and hematocrit 24 hours after the caesarian section.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National and Kapodistrian University of Athens
• Treatments: Carbetocin; Ergonovine; Maleic acid; Oxytocin

Criteria

Inclusion Criteria:

• Female gender Gestating Between 18-40 years No co-morbidity

Exclusion Criteria:

• Exclusion Criteria

• Under age parturients

• Parturients >40 years of age

• Multiple pregnancies

• Parturients with abnormal placental adhesion

• Parturients with two or more caesarian sections in the past

• Parturients with haematological diseases

• Parturients that receive anticoagulation therapy for a concomitant disease

• Parturients with severe co-morbidity

• Refusal to sign the consent form

• Caesarian section under general anaesthesia